Please consider submitting an article for this special issue. The due date is less than one month away.
Call for Papers: Experimental and Clinical Psychopharmacology
Special Issue for August 2016 on:
50th Anniversary of APA Division 28: The Past, Present and Future of Psychopharmacology and Substance Abuse
Division 28 was formed in 1966 to provide a home within APA for psychologists interested in the behavioral effects of psychoactive or central nervous system drugs and chemicals. Today, the Division's overarching mission is to encourage the advancement of knowledge on the behavioral effects of psychotropic drugs and toxicants, including (a) disseminating research-based information on psychopharmacology and substance abuse within APA, in educational settings, and to other scientists; (b) encouraging the application of the results of psychopharmacology research to human affairs; and (c) consideration of education and policy issues pertaining to psychopharmacology, behavioral toxicology, and substance abuse.
During 2016, we will celebrate the 50th anniversary of Division 28. The proposed special issue will highlight the scientific contributions and historical milestones of APA's Division 28 and its members. We invite manuscripts on the important scientific, clinical and translational contributions of Division 28 members, as well as commentary on the future of psychopharmacology and substance abuse research. In addition, collaborative, research-based manuscripts that disseminate new data about psychotropic drugs and toxicants are especially encouraged. Such papers could include novel research findings about the behavioral pharmacology of emerging drugs of abuse or newly developed compounds in non-human animals or humans (see [a], above). Research-based papers could also present new information on how aspects of psychopharmacology or substance abuse impact human affairs (see [b], above). Scholarly reflections on the notable changes that have occurred in the areas of psychopharmacology and substance abuse, particularly pertaining to education and policy (see [c], above), during the five decades since the Division was founded are also welcome.
Authors may submit primary research reports, review articles or commentaries to Experimental and Clinical Psychopharmacology to be considered for inclusion in this special issue. Manuscripts should be submitted as usual through the APA Online Submission Portal (www.apa.org/pubs/journals/pha/), and the cover letter should indicate that the authors wish the manuscript to be considered for publication in the special issue on the 50th Anniversary of Division 28. All submissions will undergo our normal peer review. Manuscripts received no later than March 1, 2016 will be considered for inclusion in the special issue. We strongly encourage individuals to contact us in advance with their ideas and ideally a draft title and abstract.
Questions or inquiries about the special issue can be directed to the Guest Editors of the issue, William W. Stoops, PhD, at firstname.lastname@example.org or Stacey C. Sigmon, PhD at email@example.com. Correspondence can also be directed to the Editor, Suzette M. Evans, PhD at firstname.lastname@example.org.
William W. Stoops, Ph.D.
phone: (859) 257-5383
facsimile: (859) 257-7684
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
Regulatory Knowledge and Support Core
University of Kentucky Center for Clinical and Translational Science
STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.